Skip to content
Search

Latest Stories

UK competition watchdog to investigate PCR Covid test price

The UK’s competition watchdog said on Thursday (August 12) it would investigate the price of PCR Covid tests ‘immediately’ and help the government in taking action against testing companies if they were found breaching consumer law.

Health Secretary Sajid Javid had written to the Competition and Markets Authority (CMA) on August 6 asking it to look into the market for PCR tests to ensure that consumers did not face unnecessarily high charges or poor service.


The CMA said in a statement that it was exploring if individual PCR providers were breaching their obligations under consumer law, and if there were structural problems in the market for PCR tests that could affect price or reliability.

It would also examine if there was any immediate action that the government could take in the meantime.

George Lusty, CMA Senior Director for Consumer Protection, said: “It is essential that people paying for PCR tests are treated fairly, get what they pay for and that their rights are respected when things go wrong. We will not hesitate to take enforcement action if we find evidence that PCR providers are breaching consumer law.

“We are also working closely with DHSC to get the data we need to identify the cause of any wider problems in the PCR testing market, and to ground our advice on what action may be needed.”

For international travel during the coronavirus pandemic, the UK has divided countries in three categories, with low-risk countries rated green for quarantine-free travel, medium risk countries rated amber, and red countries requiring arrivals to spend 10 days in isolation in a hotel.

Tests cost about £75 per person on average but there are reports of some being offered for as little as £20, and others more than £500.

All travellers from countries on the green and amber lists must book a test to be taken two days after they arrive in Britain.

Earlier, the CMA had said it would respond to Javid’s request “within a month”, which sparked an angry reaction from travel industry and people.

“...we welcome the opportunity to explore issues in the PCR testing market in more depth. We recognise that this is a very live issue, impacting consumer now, so we will tailor our work to allow us to respond within the next month,” CMA Chief Executive Andrea Coscelli CBE said in a letter addressed to the Health Secretary Sajid Javid on August 10.

More For You

Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Free morning-after pill at pharmacies to end postcode lottery for patients

Pharmacy technicians will be allowed to supply of drospirenone for contraception under PGD,

gettyimages

Pharmacy contract: Free morning-after pill to be available at pharmacies soon

The UK government has announced that, for the first time ever, the ‘morning-after pill’ or emergency contraceptive pill will be available free of charge at pharmacies on the NHS, ending the postcode lottery women face in accessing the medicine and reducing inequalities.

The Department of Health and Social Care (DHSC) has confirmed a record £3.073 billion funding package for community pharmacies in 2025/26, alongside an additional £215 million to sustain Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Royal College status: The PDA calls for ‘meaningful and collaborative dialogue’

The profession’s success will depend on collaboration across all sectors, says PDA.

gettyimages

Royal College vote: Less than 7% of GB pharmacists in favour, says PDA

The Pharmacists’ Defence Association (PDA) has criticised the Royal Pharmaceutical Society (RPS) for moving too quickly to a ballot on its proposed transition to a Royal College, arguing that it resulted in low participation from pharmacists in Great Britain.

Announcing the results of the special resolution vote, the RPS said that the outcome was a “clear mandate” in favour of the transformative change.

Keep ReadingShow less
RPS Wales calls for urgent investment in pharmacy workforce at Senedd meeting

Third from the left: Eluned Morgan, First Minister of Wales

Photo credit: RPS

Invest in pharmacy workforce: RPS Wales urges Senedd members

Members of the Senedd (MSs) were briefed on the increasing pressures facing pharmacy teams and the urgent need for action to support their health and wellbeing at an event hosted by the Royal Pharmaceutical Society (RPS) Wales.

The event, held on Wednesday, brought together MSs, including first minister Eluned Morgan, to discuss the findings of RPS’ latest Workforce Wellbeing Survey.

Keep ReadingShow less